89bio, Inc

$24.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.61 (+2.52%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell 89bio, Inc and other stocks, options, and ETFs commission-free!

About ETNB

89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases.

CEO

Rohan Palekar

Employees

Headquarters

San Francisco, California

Founded

2018

Market Cap

480.78M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

79.98K

High Today

$24.86

Low Today

$23.91

Open Price

$24.31

Volume

128.50K

52 Week High

$42.36

52 Week Low

$18.01

Analyst Ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

ETNB Earnings

-$30.63

-$20.42

-$10.21

-$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 12, After Hours